Rights and permissions
About this article
Cite this article
GLP-1-based therapies yet to reach their peak potential. Inpharma Wkly. 1656, 3–4 (2008). https://doi.org/10.2165/00128413-200816560-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816560-00003